Your browser is no longer supported. Please, upgrade your browser.
AEMD Aethlon Medical, Inc. monthly Stock Chart
Aethlon Medical, Inc.
Index- P/E- EPS (ttm)-0.79 Insider Own1.20% Shs Outstand12.07M Perf Week20.78%
Market Cap21.06M Forward P/E- EPS next Y-0.43 Insider Trans0.00% Shs Float11.77M Perf Month30.07%
Income-5.80M PEG- EPS next Q-0.15 Inst Own10.40% Short Float4.50% Perf Quarter30.99%
Sales0.60M P/S35.09 EPS this Y63.60% Inst Trans1.90% Short Ratio0.93 Perf Half Y32.86%
Book/sh1.14 P/B1.63 EPS next Y21.80% ROA-49.70% Target Price- Perf Year-43.64%
Cash/sh1.28 P/C1.45 EPS next 5Y- ROE-54.60% 52W Range0.76 - 4.34 Perf YTD93.15%
Dividend- P/FCF- EPS past 5Y36.60% ROI-67.80% 52W High-57.14% Beta0.52
Dividend %- Quick Ratio9.90 Sales past 5Y-3.10% Gross Margin- 52W Low143.46% ATR0.13
Employees8 Current Ratio9.90 Sales Q/Q- Oper. Margin- RSI (14)70.66 Volatility9.28% 7.26%
OptionableNo Debt/Eq0.00 EPS Q/Q88.70% Profit Margin- Rel Volume0.74 Prev Close1.82
ShortableNo LT Debt/Eq0.00 EarningsOct 28 AMC Payout- Avg Volume568.43K Price1.86
Recom2.00 SMA2025.08% SMA5025.56% SMA20011.75% Volume420,295 Change2.20%
Nov-03-20 08:01AM  
Oct-29-20 11:45AM  
Oct-28-20 04:15PM  
Oct-19-20 08:01AM  
Oct-13-20 10:30AM  
Sep-09-20 08:01AM  
Aug-27-20 08:01AM  
Aug-11-20 04:15PM  
Aug-06-20 12:43AM  
Jun-25-20 04:15PM  
Jun-22-20 08:31AM  
Jun-18-20 12:49PM  
Jun-16-20 08:30AM  
Mar-24-20 08:58AM  
Mar-06-20 12:08PM  
Feb-25-20 03:25PM  
Feb-24-20 10:22AM  
Feb-17-20 01:37PM  
Feb-13-20 05:35AM  
Feb-10-20 04:15PM  
Feb-06-20 08:01AM  
Jan-23-20 01:02PM  
Jan-22-20 02:28PM  
Jan-21-20 02:40PM  
Jan-17-20 08:49AM  
Dec-17-19 04:18PM  
Dec-13-19 07:00AM  
Nov-15-19 05:04AM  
Nov-01-19 04:15PM  
Oct-29-19 03:17PM  
Oct-28-19 07:00AM  
Oct-14-19 03:55PM  
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.